MedPlus quarterly net profit falls 22% as competition and expansion costs rise
Pharmacy retailer MedPlus Health Services reported a 22% decline in April–June quarterly net profit, with rising competition and costs tied to its aggressive store-expansion strategy weighing on earnings.
Pharmacy retail chain MedPlus Health Services reported a 22% decline in quarterly net profit, citing rising competition and higher costs from its aggressive store-expansion strategy.
Why this matters
The earnings decline follows MedPlus's prior Q1 update, when revenue rose 22% but profit fell on margin contraction. It also contrasts with Choice Broking's ₹889.60 breakout-buy call and ₹965 target.
Retail-company signals are accelerating, up 978500% QoQ.